Understanding LINC01551: A Potential Drug Target and Biomarker

Target Name: LINC01551

NCBI ID: G387978

LINC01551

Other Name(s): C14orf23 | long intergenic non-protein coding RNA 1551 | c14_5148 | Long intergenic non-protein coding RNA 1551, transcript variant 1 | C14_5148

Understanding LINC01551: A Potential Drug Target and Biomarker

LINC01551 (C14orf23) is a gene that has been identified as a potential drug target (or biomarker) for the treatment of various diseases, including cancer. The gene is located on chromosome 14 and has been shown to play a role in the development and progression of various diseases, including cancer.

Research has shown that LINC01551 is involved in the regulation of cell growth, apoptosis (programmed cell death), and angiogenesis (the formation of new blood vessels). It has also been shown to be involved in the development and progression of various diseases, including cancer.

One of the key challenges in studying LINC01551 is its location on chromosome 14. This makes it difficult to study because it is so far from the known gene encoding enzymes and other proteins that are involved in the regulation of cell growth and apoptosis.

However, researchers have made significant progress in the study of LINC01551. They have identified several potential drug targets that are involved in the regulation of cell growth and apoptosis. These targets include the protein encoded by the LINC01551 gene itself, as well as proteins that are known to interact with the LINC01551 gene.

In addition to its potential as a drug target, LINC01551 has also been identified as a potential biomarker for the diagnosis and prognosis of various diseases, including cancer. This is because the expression of the LINC01551 gene has been shown to be associated with the development and progression of these diseases.

Research has also shown that LINC01551 is involved in the regulation of angiogenesis, the formation of new blood vessels. This suggests that it may be a potential drug target for the treatment of diseases that are characterized by the formation of new blood vessels, such as cancer.

Overall, LINC01551 is a gene that has significant potential as a drug target and biomarker. Further research is needed to fully understand its role in the regulation of cell growth and apoptosis, as well as its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1551

The "LINC01551 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01551 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets